Selective Potentiation of Drug Cytotoxicity by NSAID in Human Glioma Cells: The Role of COX-1 and MRP
- 16 June 1999
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 259 (3), 600-605
- https://doi.org/10.1006/bbrc.1999.0825
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?Oncogene, 1998
- Chemotherapy of human malignant gliomaNeurology, 1997
- A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymesTrends in Pharmacological Sciences, 1997
- Prostaglandin G/H Synthase-2 Is a Major Contributor of Brain Prostaglandins in the NewbornOnline Journal of Public Health Informatics, 1995
- Role of Transcription Factor Egr-1 in Phorbol Ester-induced Phenylethanolamine N-Methyltransferase Gene ExpressionOnline Journal of Public Health Informatics, 1995
- Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.JCI Insight, 1994
- Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.JCI Insight, 1994
- Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Cloning Two Isoforms of Rat Cyclooxygenase: Differential Regulation of Their ExpressionArchives of Biochemistry and Biophysics, 1993
- Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissuesFEBS Letters, 1993